Baoming Wang

Dr. Baoming Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
YLYue Li
Yue Li
BWBaoming Wang
Baoming Wang
CWChunyang Wang
Chunyang Wang
DZDandan Zhao
Dandan Zhao
ZLZhengchuang Liu
Zhengchuang Liu
TLTao Li
Tao Li
Background: In contrast to Caucasian melanoma, which has been extensively studied, there are few studies on melanoma in Asian populations. Sporadic studies reported that only 40% of Asian melanoma patients could be druggable, which was much lower than that in Caucasians. More studies are required to refine this conclusion. Methods: Chinese melanoma patients (n = 469) were sequentially sequenced by DNA-NGS and RNA-NGS. The genomic alterations were determined, and potentially actionable targets were investigated. Results: Patients with potential druggable targets were identified in 75% of Chinese melanoma patients by DNA-NGS based on OncoKB, which was much higher than in a previous Asian study. NRG1 fusions were first identified in melanoma. In addition, up to 11.7% (7/60) of patients in the undruggable group could be recognized as actionable by including RNA-NGS analysis. By comparing the fusion detection rate between DNA-NGS and RNA-NGS, all available samples after DNA-NGS detection were further verified by RNA-NGS. The use of RNA-NGS enhanced the proportion of druggable fusions from 2.56% to 17.27%. In total, the use of RNA-NGS increased the druggable proportion from 75% to 78%. Conclusions: In this study, we systemically analyzed the actionable landscape of melanoma in the largest Asian cohort. In addition, we first demonstrated how DNA and RNA sequential sequencing is essential in bringing clinical benefits to more patients with melanoma.

31 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
BWBaoming Wang
Baoming Wang
FZFayan Zhang
Fayan Zhang
FCFangfang Chen
Fangfang Chen
PLPeng Li
Peng Li
YHYujie He
Yujie He
BSBaoxia Sun
Baoxia Sun
Aim. To explore the potential relationship between NLR and micronutrient deficiency in patients with severe COVID‐19 infection. Methods. Sixteen patients were categorized into the mild group (mild COVID‐19) and severe group (severe COVID‐19) based on the guideline of the management of COVID‐19. The lactate dehydrogenase (LDH); superoxide dismutase (SOD), the inflammatory markers (neutrophil lymphocyte ratio (NLR)), erythrocyte sedimentation rate (ESR), c‐reactive protein (CRP), selenium (Se), iron (Fe), zinc (Zn), nickel (Ni), copper (Cu), chromium (Cr), cadmium (Cd), arsenic (As), and manganese (Mn) were measured in the blood. Results. Compared to the mild group, the NLR (P < 0.05) and the level of Se (P < 0.01), Fe (P < 0.05), and Zn (P < 0.05) were significantly decreased in the severe group. The level of Se, Fe, and Zn was significantly correlated to NLR levels. Furthermore, close positive correlation was found between NLR and severity of COVID‐19. Conclusion. The micronutrient deficiency in the blood is associated with NLR in the severity of COVID‐19 patients.

1 November 2017 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
YLY. Liu
Y. Liu
XHXingsheng Hu
Xingsheng Hu
JJJingmei Jiang
Jingmei Jiang
BWBaoming Wang
Baoming Wang
PLP. Liu
P. Liu
YSYajun Shi
Yajun Shi


12 June 2019 in Hematological Oncology
Verified
Journal Article
Open access
PDF file
PLP. Liu
P. Liu
YHYing Han
Ying Han
SJS. Jiang
S. Jiang
XHX. He
X. He
YQY. Qin
Y. Qin
YSYuan-kai Shi
Yuan-kai Shi